Executive Solution Overview
**files (2)** – ## Nu553Unit5assignment.docx – ## NU553_Unit_5_Template.docx **## Nu553Unit5assignment.docx** Nu553 Unit 5 assignment In this assignment you will examine effective communication and shared decision-making modalities for patients, families, and the interprofessional team for both p…
Instant Solution Download
$6.99Immediate access to the full model answer, formatted citations, and rubric breakdown.
Need a Fresh Custom Paper?
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Assignment Prompt & Instructions
**files (2)**
– ## Nu553Unit5assignment.docx
– ## NU553_Unit_5_Template.docx
**## Nu553Unit5assignment.docx**
Nu553 Unit 5 assignment
In this assignment you will examine effective communication and shared decision-making modalities for patients, families, and the interprofessional team for both prescriptive and nonprescriptive drug therapies, taking into consideration determinants of health with regards to thromboembolic disorders.
· Access the Unit 5 template and ensure you complete your name and the required information. Use the headers in the template provided.
· Begin with an introductory paragraph on general considerations related to safe anticoagulation therapy and the role of these agents.
· Next include content regarding prescribing, communicating and educating with patients and families. Include lab monitoring considerations and safety in the home, medication compliance etc. Specific values of labs should be addressed.
· Address communication pathways with the interprofessional team. Pharmacy, nursing, physician, cardiology, intermedicine etc., regarding medical management.
· Next include content on shared decision making with these drugs. Address patients/ families and interprofessional teams separately.
· Finally in the commentary portions include content regarding nonprescriptive drug therapies that may interact or be contraindicated and why.
· Include content how determinants of health such as biology/ genetics and/ or comorbidities
· Finally provide a summary.
· Provide 4-5 sentences per section.
· Then complete the table component within the template. You must list one specific drug in each class and place the name of the drug under the class.
· Refer to your text and readings to help you choose a drug from the class. Include 2-4 items/ key points per section based on your literature search.
· The last section of the table should have content on the use of the drug regarding therapeutic monitoring, labs for monitoring and goals of therapy
· Refer to the required reading, resources and internet research to help you.
· The template sections will expand as you add content. Use key words with bulleted content or brief descriptions. Do not paste large content.
· You will have addressed 7 medications one from each listed classification.
· You may add the citation under the drug names. Include references on your reference page.
· Keep the headings within the essay portion bolded. Polish and keep the template and the table neat. Be sure the font is Ariel 10 within the table. It should be readable, meaningful, organized and not wordy.
**## NU553_Unit_5_Template.docx**
**NU553 Unit 5 Template**
Review the
[grading rubric](https://kapextmediassl-a.akamaihd.net/nursing/NU553/NU553_2601A/NU553_Unit_5_Assignment_Rubric.docx).
**Communication, Shared Decision Making and Interprofessional Teams in Thromboembolic Disorders**
**Student Name:**
**Date:**
**Instructor Name:**
**Introduction**
**Communication Techniques**
**Patients and Families.**
**Interprofessional Teams.**
**Shared Decision Making**
**Patients and Families.**
**Interprofessional Teams.**
**Nonprescriptive Considerations**
**Determinants of Health Considerations**
| | | | | | | | |
| — | — | — | — | — | — | — | — |
| Anticoagulant Agents |
| **Drug Class**<br>**Drug Name**<br>**Brand/**<br>**Generic** | **Indications and Uses** | **Mechanism of Action** | **Dosage and Considerations** | **Interactions** | **Contraindications** | **Antedote** | **Monitoring**<br>**Goals/ Labs** |
| **UFH** | | | | | | | |
| **LMWH** | | | | | | | |
| **VKA** | | | | | | | |
| **DOAC (DTI)** | | | | | | | |
| **DOAC (Xa Inhibitor)** | | | | | | | |
| **APT** | | | | | | | |
| **tPA**<br>**_Thrombolytic_** | | | | | | | |
Anticoagulants include the injectable agents unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs), oral vitamin K antagonist (VKA) warfarin, and the DOACs (a direct thrombin inhibitors), and oral factor Xa inhibitors. Recombinant tissue plasminogen activators (rtPAs) are thrombolytic agents. Antiplatelet therapy (APT).
References
**## NU553_Unit_5_Template.docx**
**NU553 Unit 5 Template**
Review the
[grading rubric](https://kapextmediassl-a.akamaihd.net/nursing/NU553/NU553_2601A/NU553_Unit_5_Assignment_Rubric.docx).
**Communication, Shared Decision Making and Interprofessional Teams in Thromboembolic Disorders**
**Student Name:**
**Date:**
**Instructor Name:**
**Introduction**
**Communication Techniques**
**Patients and Families.**
**Interprofessional Teams.**
**Shared Decision Making**
**Patients and Families.**
**Interprofessional Teams.**
**Nonprescriptive Considerations**
**Determinants of Health Considerations**
| | | | | | | | |
| — | — | — | — | — | — | — | — |
| Anticoagulant Agents |
| **Drug Class**<br>**Drug Name**<br>**Brand/**<br>**Generic** | **Indications and Uses** | **Mechanism of Action** | **Dosage and Considerations** | **Interactions** | **Contraindications** | **Antedote** | **Monitoring**<br>**Goals/ Labs** |
| **UFH** | | | | | | | |
| **LMWH** | | | | | | | |
| **VKA** | | | | | | | |
| **DOAC (DTI)** | | | | | | | |
| **DOAC (Xa Inhibitor)** | | | | | | | |
| **APT** | | | | | | | |
| **tPA**<br>**_Thrombolytic_** | | | | | | | |
Anticoagulants include the injectable agents unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs), oral vitamin K antagonist (VKA) warfarin, and the DOACs (a direct thrombin inhibitors), and oral factor Xa inhibitors. Recombinant tissue plasminogen activators (rtPAs) are thrombolytic agents. Antiplatelet therapy (APT).
References
**## Nu553Unit5assignment.docx**
Nu553 Unit 5 assignment
In this assignment you will examine effective communication and shared decision-making modalities for patients, families, and the interprofessional team for both prescriptive and nonprescriptive drug therapies, taking into consideration determinants of health with regards to thromboembolic disorders.
· Access the Unit 5 template and ensure you complete your name and the required information. Use the headers in the template provided.
· Begin with an introductory paragraph on general considerations related to safe anticoagulation therapy and the role of these agents.
· Next include content regarding prescribing, communicating and educating with patients and families. Include lab monitoring considerations and safety in the home, medication compliance etc. Specific values of labs should be addressed.
· Address communication pathways with the interprofessional team. Pharmacy, nursing, physician, cardiology, intermedicine etc., regarding medical management.
· Next include content on shared decision making with these drugs. Address patients/ families and interprofessional teams separately.
· Finally in the commentary portions include content regarding nonprescriptive drug therapies that may interact or be contraindicated and why.
· Include content how determinants of health such as biology/ genetics and/ or comorbidities
· Finally provide a summary.
· Provide 4-5 sentences per section.
· Then complete the table component within the template. You must list one specific drug in each class and place the name of the drug under the class.
· Refer to your text and readings to help you choose a drug from the class. Include 2-4 items/ key points per section based on your literature search.
· The last section of the table should have content on the use of the drug regarding therapeutic monitoring, labs for monitoring and goals of therapy
· Refer to the required reading, resources and internet research to help you.
· The template sections will expand as you add content. Use key words with bulleted content or brief descriptions. Do not paste large content.
· You will have addressed 7 medications one from each listed classification.
· You may add the citation under the drug names. Include references on your reference page.
· Keep the headings within the essay portion bolded. Polish and keep the template and the table neat. Be sure the font is Ariel 10 within the table. It should be readable, meaningful, organized and not wordy.
**## NU553_Unit_5_Template.docx**
**NU553 Unit 5 Template**
Review the
[grading rubric](https://kapextmediassl-a.akamaihd.net/nursing/NU553/NU553_2601A/NU553_Unit_5_Assignment_Rubric.docx).
**Communication, Shared Decision Making and Interprofessional Teams in Thromboembolic Disorders**
**Student Name:**
**Date:**
**Instructor Name:**
**Introduction**
**Communication Techniques**
**Patients and Families.**
**Interprofessional Teams.**
**Shared Decision Making**
**Patients and Families.**
**Interprofessional Teams.**
**Nonprescriptive Considerations**
**Determinants of Health Considerations**
| | | | | | | | |
| — | — | — | — | — | — | — | — |
| Anticoagulant Agents |
| **Drug Class**<br>**Drug Name**<br>**Brand/**<br>**Generic** | **Indications and Uses** | **Mechanism of Action** | **Dosage and Considerations** | **Interactions** | **Contraindications** | **Antedote** | **Monitoring**<br>**Goals/ Labs** |
| **UFH** | | | | | | | |
| **LMWH** | | | | | | | |
| **VKA** | | | | | | | |
| **DOAC (DTI)** | | | | | | | |
| **DOAC (Xa Inhibitor)** | | | | | | | |
| **APT** | | | | | | | |
| **tPA**<br>**_Thrombolytic_** | | | | | | | |
Anticoagulants include the injectable agents unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs), oral vitamin K antagonist (VKA) warfarin, and the DOACs (a direct thrombin inhibitors), and oral factor Xa inhibitors. Recombinant tissue plasminogen activators (rtPAs) are thrombolytic agents. Antiplatelet therapy (APT).
References
**## Nu553Unit5assignment.docx**
Nu553 Unit 5 assignment
In this assignment you will examine effective communication and shared decision-making modalities for patients, families, and the interprofessional team for both prescriptive and nonprescriptive drug therapies, taking into consideration determinants of health with regards to thromboembolic disorders.
· Access the Unit 5 template and ensure you complete your name and the required information. Use the headers in the template provided.
· Begin with an introductory paragraph on general considerations related to safe anticoagulation therapy and the role of these agents.
· Next include content regarding prescribing, communicating and educating with patients and families. Include lab monitoring considerations and safety in the home, medication compliance etc. Specific values of labs should be addressed.
· Address communication pathways with the interprofessional team. Pharmacy, nursing, physician, cardiology, intermedicine etc., regarding medical management.
· Next include content on shared decision making with these drugs. Address patients/ families and interprofessional teams separately.
· Finally in the commentary portions include content regarding nonprescriptive drug therapies that may interact or be contraindicated and why.
· Include content how determinants of health such as biology/ genetics and/ or comorbidities
· Finally provide a summary.
· Provide 4-5 sentences per section.
· Then complete the table component within the template. You must list one specific drug in each class and place the name of the drug under the class.
· Refer to your text and readings to help you choose a drug from the class. Include 2-4 items/ key points per section based on your literature search.
· The last section of the table should have content on the use of the drug regarding therapeutic monitoring, labs for monitoring and goals of therapy
· Refer to the required reading, resources and internet research to help you.
· The template sections will expand as you add content. Use key words with bulleted content or brief descriptions. Do not paste large content.
· You will have addressed 7 medications one from each listed classification.
· You may add the citation under the drug names. Include references on your reference page.
· Keep the headings within the essay portion bolded. Polish and keep the template and the table neat. Be sure the font is Ariel 10 within the table. It should be readable, meaningful, organized and not wordy.
**## NU553_Unit_5_Template.docx**
**NU553 Unit 5 Template**
Review the
[grading rubric](https://kapextmediassl-a.akamaihd.net/nursing/NU553/NU553_2601A/NU553_Unit_5_Assignment_Rubric.docx).
**Communication, Shared Decision Making and Interprofessional Teams in Thromboembolic Disorders**
**Student Name:**
**Date:**
**Instructor Name:**
**Introduction**
**Communication Techniques**
**Patients and Families.**
**Interprofessional Teams.**
**Shared Decision Making**
**Patients and Families.**
**Interprofessional Teams.**
**Nonprescriptive Considerations**
**Determinants of Health Considerations**
| | | | | | | | |
| — | — | — | — | — | — | — | — |
| Anticoagulant Agents |
| **Drug Class**<br>**Drug Name**<br>**Brand/**<br>**Generic** | **Indications and Uses** | **Mechanism of Action** | **Dosage and Considerations** | **Interactions** | **Contraindications** | **Antedote** | **Monitoring**<br>**Goals/ Labs** |
| **UFH** | | | | | | | |
| **LMWH** | | | | | | | |
| **VKA** | | | | | | | |
| **DOAC (DTI)** | | | | | | | |
| **DOAC (Xa Inhibitor)** | | | | | | | |
| **APT** | | | | | | | |
| **tPA**<br>**_Thrombolytic_** | | | | | | | |
Anticoagulants include the injectable agents unfractionated heparin (UFH) and low-molecular-weight heparins (LMWHs), oral vitamin K antagonist (VKA) warfarin, and the DOACs (a direct thrombin inhibitors), and oral factor Xa inhibitors. Recombinant tissue plasminogen activators (rtPAs) are thrombolytic agents. Antiplatelet therapy (APT).
References
Leave a Reply